Vaccine to prevent two meningitis types at once developed in Bashkortostan

Print 16 April 2015
Marchmont Innovation News

Scientists in Ufa, in the Volga region of Bashkortostan, have come up with a combined vaccine for two different types of meningitis, the website of the Vesti TV channel reported . There have traditionally been separate vaccines for each of the types. 

This is said to be a joint product by the Ufa biochemical researchers and their Moscow-based colleagues. 

The new vaccine is designed to prevent meningococcal meningitis of the A and C types, one of the most dangerous among infections. The disease may be accompanied by sepsis and bring meningitis to the mucous membrane of nasal pharynx and the brain. The mortality rate is high, and so are serious complications. 

An experimental series of the new drug candidate is currently undergoing preclinical trials. The bulk of research into its toxicity and immunogenicity was completed by the end of last year already. The future drug will be “much less expensive than international analogs and won’t be second to those in quality,” the source said.

Source

Return